BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li S, Zhao H, Mao X, Fan Y, Liang X, Wang R, Xiao L, Wang J, Liu Q, Zhao G. Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate. Pharm Res 2019;36. [DOI: 10.1007/s11095-019-2688-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang B, Wang T, Yang Y, Zhu H, Li J. The application progress of peptides in drug delivery systems in the past decade. Journal of Drug Delivery Science and Technology 2021;66:102880. [DOI: 10.1016/j.jddst.2021.102880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Dhaini B, Kenzhebayeva B, Ben-mihoub A, Gries M, Acherar S, Baros F, Thomas N, Daouk J, Schohn H, Hamieh T, Frochot C. Peptide-conjugated nanoparticles for targeted photodynamic therapy. Nanophotonics 2021;10:3089-134. [DOI: 10.1515/nanoph-2021-0275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Yang A, Sun Z, Liu R, Liu X, Zhang Y, Zhou Y, Qiu Y, Zhang X. Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress. Front Oncol 2021;11:727605. [PMID: 34513705 DOI: 10.3389/fonc.2021.727605] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Alas M, Saghaeidehkordi A, Kaur K. Peptide-Drug Conjugates with Different Linkers for Cancer Therapy. J Med Chem 2021;64:216-32. [PMID: 33382619 DOI: 10.1021/acs.jmedchem.0c01530] [Cited by in Crossref: 10] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
5 Chen L, Chen G, Yang Z, Wang H, Liu N, Liu Y, Fang K, Song Y, Guan X. Enhanced cancer treatment by an acid-sensitive cytotoxic peptide-doxorubicin conjugate. Journal of Drug Delivery Science and Technology 2020;60:102048. [DOI: 10.1016/j.jddst.2020.102048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Deng X, Mai R, Zhang C, Yu D, Ren Y, Li G, Cheng B, Li L, Yu Z, Chen J. Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment. Eur J Med Chem 2021;213:113050. [PMID: 33280896 DOI: 10.1016/j.ejmech.2020.113050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
7 Kunjiappan S, Pavadai P, Vellaichamy S, Ram Kumar Pandian S, Ravishankar V, Palanisamy P, Govindaraj S, Srinivasan G, Premanand A, Sankaranarayanan M, Theivendren P. Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review. Drug Dev Res 2021;82:309-40. [DOI: 10.1002/ddr.21758] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]